January 17, 2017 12:00 AM ET

Pharmaceuticals

Company Overview of U3 Pharma GmbH

Key Executives for U3 Pharma GmbH

NameBoard RelationshipsTitleAge
Johannes Bange No RelationshipsCo-Founder, Chief Executive Officer and Member of Board of Management--
Reimar Abraham No RelationshipsCo-Founder and Director of R&D--
Jens Ruhe No RelationshipsCo-Founder and Director of R&D--
Axel Ullrich Ph.D.36 RelationshipsScientific Founder and Director72
Esther Zwick-Wallasch No RelationshipsCo-Founder and Director of R&D--
View More Key Executives

U3 Pharma GmbH Board Members*

NameBoard RelationshipsPrimary CompanyAge
Junichi Koga 11 RelationshipsDaiichi Sankyo Company, Limited--
Axel Ullrich Ph.D. 36 RelationshipsEvotec (München) GmbH72
Joël Besse 10 RelationshipsOrion Healthcare Equity Partners51
Joachim Rothe Ph.D. 43 RelationshipsLife Sciences Partners BV52
Martin Hesse 5 RelationshipsDaiichi Sankyo Europe GmbH51
View All Board Members

U3 Pharma GmbH Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Supervisory Board Junichi Koga11 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
389.4K
Bonus
492.0K
Total Short Term Compensation
567.1K
Total Value of Options
15.0M
Compensation as of Fiscal Year
U3 Pharma GmbH CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Noxopharm Limited Announces Management Changes
January 16, 2017 1:03 AM ET
Mayne Pharma Group Limited Announces Management Appointments
January 15, 2017 9:29 PM ET
Alliance Growers Corp Appoints Ian Lambert to the Board of Directors
January 13, 2017 11:23 PM ET
Eli Lilly and Company Appoints Martin Bott to Board of Directors
January 13, 2017 8:42 PM ET
Matthew Rhoden Resigns as Chief Executive Officer and Director of Evergreen Agra, Inc
January 13, 2017 6:47 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact U3 Pharma GmbH, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.